RxDoctor Payments DataLook up a doctor →

Brent Mohr, MD

Rheumatology · South Bend, INNPI 1710977319

Payments from drug & device makers

$10,352in general payments, 2019–2025

Across 536 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$6K
  • Amgen$2K
  • Lilly USA, LLC$636
  • Novartis$626
  • UCB, Inc.$218
  • Pfizer$217
  • plus $480 from 5 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie355$6,399
Amgen(2 entities)89$1,775
Lilly USA, LLC22$636
Novartis28$626
UCB, Inc.15$218
Pfizer12$217
Genentech USA, Inc.5$182
Aurinia Pharma U.S., Inc.2$141
E.r. Squibb & Sons, L.L.C.5$108
Johnson & Johnson2$35
GSK1$14

How this compares

$10,352 in reported general payments places this provider in the 80th percentile of 106 rheumatology providers in Indiana.

See all rheumatology providers in Indiana

Medicare billing

Part B allowed, 2024
$3,150,639
Medicare patients
527
Services billed
182,782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →